Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
logo icon CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Congratulations on the Successful Listing of Kintor Pharma

2020-05-26
|
Page View:

On May 22, 2020, Kintor Pharmaceutical Limited (stock code: 9939. HK) was officially listed on the Hong Kong Stock Exchange. We medicilon extend the congratulations and best wishes.


Listing-of-Kintor-Pharma


Medicilon has joined hands with in multiple pharmaceutical development projects in recent years, including external preclinical pharmacokineticstudies and safety evaluation of the androgen receptor antagonist Frestatin (KX-826) and related trials of other drug compounds. The PK and safety evaluation tests of KX-826 completed by Medicilon supports both FDA and NMPA IND filing. In addition, the drug safety evaluation of KX-826 is carried out using mini-pigs as the test species, supporting all stages from preclinical to phases I, II and III clinical trials.

Relevant newsRelevant news